Showing 2,181 - 2,200 results of 103,993 for search '(( 5 ((((ng decrease) OR (mean decrease))) OR (a decrease)) ) OR ( e point decrease ))', query time: 1.60s Refine Results
  1. 2181
  2. 2182
  3. 2183
  4. 2184
  5. 2185

    Loss of Rumi leads to intracellular accumulation and decreased IRS levels of Eys in a temperature dependent manner at the mid-pupal stage. by Amanda R. Haltom (664189)

    Published 2014
    “…White arrowheads mark points of rhabdomere attachment and gaps in Eys. (E,E′) A single ommatidium from a wild-type animal at 55% PD shifted to 30°C during IRS formation. …”
  6. 2186
  7. 2187
  8. 2188
  9. 2189
  10. 2190

    Bortezomib in combination with the PLK1 inhibitor BI 2536 induces a significant downregulation of the total levels and phosphorylation of Bcr-Abl, a decrease of downstream phosphorylated STAT5 and a caspase-dependent cell death in TKIs-resistant and –sensitive K562 cell lines. by Octavian Bucur (470431)

    Published 2013
    “…K562 and K562-R cells were treated with 9nM bortezomib and 8nM BI 2536 for 60h, followed by the detection of Bcr-Abl and phosphorylated STAT5. The combined treatment resulted in a marked decrease of the total levels of Bcr-Abl, which correlates with a decrease in the phosphorylation of the downstream STAT5 protein, in both K562 and K562-R cells. β-Actin was used as an internal loading control. …”
  11. 2191
  12. 2192
  13. 2193
  14. 2194
  15. 2195
  16. 2196

    Image2_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

    Published 2021
    “…IL-33 plays a role in venous neointimal hyperplasia both in humans and rats; neutralization of IL-33 by IL-33 antibody can be a therapeutic method to decrease venous neointimal hyperplasia.…”
  17. 2197

    Image1_A Novel Plant Leaf Patch Absorbed With IL-33 Antibody Decreases Venous Neointimal hyperplasia.TIFF by Boao Xie (11621803)

    Published 2021
    “…IL-33 plays a role in venous neointimal hyperplasia both in humans and rats; neutralization of IL-33 by IL-33 antibody can be a therapeutic method to decrease venous neointimal hyperplasia.…”
  18. 2198
  19. 2199
  20. 2200